Evaluating the Persona Knee Implant for Total Knee Replacement
Persona® OsseoTi® Keel Compatibility Study-A Multicenter Cohort Study A Prospective, Post-market Clinical Follow-up Study to Demonstrate Safety, Performance and Clinical Benefits of the Persona Knee System Portfolio and Its Instrumentation
This study is testing the Persona knee implant in people getting total knee replacement surgery to see how safe and effective it is over the next 10 years.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 760 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Zimmer Biomet Industry-sponsored |
| Locations | 16 sites (Parker, Colorado and 15 other locations) |
| Trial ID | NCT05787821 on ClinicalTrials.gov |
What this trial studies
This observational study aims to assess the safety, performance, and clinical benefits of the Persona Total Knee System in patients undergoing primary total knee arthroplasty. It involves a multicenter data collection model where participants will undergo preoperative evaluations and will be followed for up to 10 years post-surgery. Clinical data will be collected through patient-reported outcomes and radiographic assessments to ensure the device meets its intended performance standards.
Who should consider this trial
Good fit: Ideal candidates include adults who are skeletally mature and qualify for primary or revision total knee arthroplasty based on their medical history and physical examination.
Not a fit: Patients currently involved in other surgical interventions or pain management studies, as well as pregnant individuals, may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the effectiveness and safety of total knee arthroplasty for patients suffering from knee pain and related conditions.
How similar studies have performed: Other studies evaluating similar knee implant systems have shown promising results, indicating that this approach is supported by prior research.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Patient is of legal age and skeletally mature 2. Patient is willing and able to provide written Informed Consent by signing and dating the Institutional Review Board (IRB) / Ethics Committee (EC) approved Informed Consent document 3. Patient is willing and able to complete scheduled follow-up evaluations as defined in the study protocol 4. Independent of study participation, patient qualifies for either cemented or cementless primary or revision total knee arthroplasty (including salvage of previously failed surgical attempts) based upon physical exam and medical history, and meets the approved indications for use of the commercially available Persona Knee System with appropriately matched Zimmer Biomet components implanted in accordance with product labeling Exclusion Criteria: 1. Patient is currently participating in any other surgical intervention or pain management study 2. Patient is pregnant or considered a member of a protected (vulnerable) population whose inclusion in the study is inappropriate (e.g. prisoner, mentally incompetent) 3. Patient has a mental or neurological condition who is unwilling or incapable of following postoperative care instructions 4. Patient has a condition which would, in the judgment of the investigator, place the patient at undue risk or interfere with the conduct of the study 5. Patient is institutionalized or is a known drug abuser, a known alcoholic or cannot understand the requirements of study participation 6. Patient is scheduled to undergo simultaneous bilateral total knee arthroplasty 7. Previous history of infection in the affected joint and/or other local/systemic infection that may affect the prosthetic joint 8. Insufficient bone stock on femoral or tibial surfaces 9. Neuropathic arthropathy 10. Osteoporosis or any loss of musculature or neuromuscular disease that compromises the affected limb 11. A stable, painless arthrodesis in a satisfactory functional position 12. Severe instability secondary to the absence of collateral ligament integrity 13. Rheumatoid Arthritis (RA) accompanied by an ulcer of the skin or a history of recurrent breakdown of the skin 14. Patient has a \> 5˚ valgus deformity with a medial collateral ligament (MCL) insufficiency, and the surgeon intends to use the personalized alignment surgical technique
Where this trial is running
Parker, Colorado and 15 other locations
- Denver Hip & Knee, Inc. — Parker, Colorado, United States (Recruiting)
- Foundation for Orthopaedic Research & Education — Tampa, Florida, United States (Recruiting)
- Northside Hospital, Inc. — Atlanta, Georgia, United States (Active_not_recruiting)
- U of L Health — Louisville, Kentucky, United States (Recruiting)
- University of Michigan — Ann Arbor, Michigan, United States (Active_not_recruiting)
- Mayo Clinic — Rochester, Minnesota, United States (Recruiting)
- Mississippi Sports Medicine and Orthopaedic Center — Jackson, Mississippi, United States (Active_not_recruiting)
- New Mexico Orthopaedic Associates — Albuquerque, New Mexico, United States (Recruiting)
- Syracuse Orthopaedic Specialists — DeWitt, New York, United States (Recruiting)
- NYU — New York, New York, United States (Recruiting)
- St. Francis Hospital & Heart Center — Roslyn, New York, United States (Recruiting)
- OrthoCarolina Research Institute, Inc. — Charlotte, North Carolina, United States (Recruiting)
- Duke University — Morrisville, North Carolina, United States (Recruiting)
- Cleveland Clinic — Cleveland, Ohio, United States (Recruiting)
- UT Health at Houston — Houston, Texas, United States (Recruiting)
- UVA Health Orthopedic Center — Charlottesville, Virginia, United States (Active_not_recruiting)
Study contacts
- Study coordinator: Erik Kowalski, PhD
- Email: erik.kowalski@zimmerbiomet.com
- Phone: 6473316652
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.